SCHEMBL6265338

SCHEMBL6265338

CC(C)(C)OC(=O)c1c(-c2ccc(Cl)cc2Cl)c[nH]c1CCCNc1ccc([N+](=O)[O-])c(N)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.48
GSK3A P49840 3/20 0.48
CDK1 P06493 2/20 0.48
CCNB2 O95067 1/20 0.48
CCNB1 P14635 1/20 0.48
CCNB3 Q8WWL7 1/20 0.48
CNR1 P21554 2/20 0.35
CNR2 P34972 2/20 0.35
MAPT P10636 3/20 0.33
PLA2G1B P04054 1/20 0.33
ATG4B Q9Y4P1 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
PTGDR Q13258 3/20 0.31
ALDH1A1 P00352 1/20 0.31
SIRT5 Q9NXA8 1/20 0.31
DPP4 P27487 1/20 0.31
SCN9A Q15858 1/20 0.30
SCN2A Q99250 1/20 0.30
SCN3A Q9NY46 1/20 0.30
SCN10A Q9Y5Y9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6429858 0.90 GSK3B (0.52) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL6210081 0.80 GSK3B (0.51) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL1219461 0.80 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2909927 0.79 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL6212610 0.77 GSK3B (0.67) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL6208619 0.77 GSK3B (0.46) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL6213250 0.77 GSK3B (0.51) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL6026865 0.77 CNR1 (0.41) CNR1CNR2MAPTDPP4ALPL
SCHEMBL6028953 0.75 GSK3B (0.38) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL6211337 0.74 GSK3A (0.33) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608369-A2 USE OF ORGANIC COMPOUNDS FOR IMMUNOPOTENTIATION CHIRON CORPORATION (US) 2005-12-28 EP disclosed
EP-1537099-A1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2005-06-08 EP disclosed
WO-2004087153-A2 USE OF ORGANIC COMPOUNDS FOR IMMUNOPOTENTIATION CHIRON CORPORATION (US) 2004-10-14 WO disclosed
WO-2004018455-A1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2004-03-04 WO disclosed